A Functional Polymorphism in the Promoter Region of IL-33 Is Associated with the Reduced Risk of Colorectal Cancer

References

• Lu H , OuyangW, HuangC. Inflammation, a key event in cancer development. Mol. Cancer Res.4(4), 221–233 (2006).
   PubMed Web of Science ®Google Scholar
• Moss SF , BlaserMJ. Mechanisms of disease: inflammation and the origins of cancer. Nat. Clin. Pract. Oncol.2(2), 90–97 (2005).
   PubMedGoogle Scholar
• Stidham RW , HigginsPDR. Colorectal cancer in inflammatory bowel disease. Clin. Colon Rectal Surg.31(3), 168–178 (2018).
   PubMed Web of Science ®Google Scholar
• Triantafillidis JK , NasioulasG, KosmidisPA. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res.29(7), 2727–2737 (2009).
   PubMed Web of Science ®Google Scholar
• Shawki S , AshburnJ, SignsSA, HuangE. Colon cancer: inflammation-associated cancer. Surg. Oncol. Clin. N. Am.27(2), 269–287 (2018).
   PubMed Web of Science ®Google Scholar
• Eaden JA , AbramsKR, MayberryJF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut48(4), 526–535 (2001).
   PubMed Web of Science ®Google Scholar
• von Roon AC , ReeseG, TeareJ, ConstantinidesV, DarziAW, TekkisPP. The risk of cancer in patients with Crohn’s disease. Dis. Colon Rectum50(6), 839–855 (2007).
   PubMed Web of Science ®Google Scholar
• Akimoto M , TakenagaK. Role of the IL-33/ST2L axis in colorectal cancer progression. Cell Immunol.doi: https://doi.org/10.1016/j.cellimm.2017.12.014 (2018) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Maywald RL , DoernerSK, PastorelliLet al. IL-33 activates tumor stroma to promote intestinal polyposis. Proc. Natl Acad. Sci. USA112(19), E2487–2496 (2015).
   PubMed Web of Science ®Google Scholar
• Baekkevold ES , RoussigneM, YamanakaTet al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am. J. Pathol.163(1), 69–79 (2003).
   PubMed Web of Science ®Google Scholar
• Hsu CL , BrycePJ. Inducible IL-33 expression by mast cells is regulated by a calcium-dependent pathway. J. Immunol.189(7), 3421–3429 (2012).
   PubMed Web of Science ®Google Scholar
• Wood IS , WangB, TrayhurnP. IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. Biochem. Biophys. Res. Commun.384(1), 105–109 (2009).
   PubMed Web of Science ®Google Scholar
• Nomura K , KojimaT, FuchimotoJet al. Regulation of interleukin-33 and thymic stromal lymphopoietin in human nasal fibroblasts by proinflammatory cytokines. Laryngoscope122(6), 1185–1192 (2012).
   PubMed Web of Science ®Google Scholar
• Moussion C , OrtegaN, GirardJP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’?PLoS ONE3(10), e3331 (2008).
   PubMed Web of Science ®Google Scholar
• Liu X , ZhuL, LuXet al. IL-33/ST2 pathway contributes to metastasis of human colorectal cancer. Biochem. Biophys. Res. Commun.453(3), 486–492 (2014).
   PubMed Web of Science ®Google Scholar
• Carriere V , RousselL, OrtegaNet al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl Acad. Sci. USA104(1), 282–287 (2007).
   PubMed Web of Science ®Google Scholar
• Ali S , MohsA, ThomasMet al. The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription. J. Immunol.187(4), 1609–1616 (2011).
   PubMed Web of Science ®Google Scholar
• Lu B , YangM, WangQ. Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy. J. Mol. Med.94(5), 535–543 (2016).
   PubMed Web of Science ®Google Scholar
• Sedhom MA , PicheryM, MurdochJRet al. Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut62(12), 1714–1723 (2013).
   PubMed Web of Science ®Google Scholar
• Cui G , QiH, GundersenMDet al. Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer. Cancer Immunol. Immunother.64(2), 181–190 (2015).
   PubMed Web of Science ®Google Scholar
• Mertz KD , MagerLF, WasmerMHet al. The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice. Oncoimmunology5(1), e1062966 (2016).
   PubMed Web of Science ®Google Scholar
• Zhang Y , DavisC, ShahSet al. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis. Mol. Carcinog.56(1), 272–287 (2017).
   PubMed Web of Science ®Google Scholar
• Ghazi S , Von HolstS, PicelliSet al. Colorectal cancer susceptibility loci in a population-based study: associations with morphological parameters. Am. J. Pathol.177(6), 2688–2693 (2010).
   PubMed Web of Science ®Google Scholar
• Poynter JN , FigueiredoJC, ContiDVet al. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the colon cancer family registry. Cancer Res.67(23), 11128–11132 (2007).
   PubMed Web of Science ®Google Scholar
• Zanke BW , GreenwoodCM, RangrejJet al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat. Genet.39(8), 989–994 (2007).
   PubMed Web of Science ®Google Scholar
• Kocarnik JD , HutterCM, SlatteryMLet al. Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis. Cancer Epidemiol. Biomarkers Prev.19(12), 3131–3139 (2010).
   PubMed Web of Science ®Google Scholar
• Tu X , NieS, LiaoYet al. The IL-33-ST2L pathway is associated with coronary artery disease in a Chinese Han population. Am. J. Hum. Genet.93(4), 652–660 (2013).
   PubMed Web of Science ®Google Scholar
• Li PP , ZhangXM, YuanD, LiuX, LiY, ShanNN. Decreased expression of IL-33 in immune thrombocytopenia. Int. Immunopharmacol.28(1), 420–424 (2015).
   PubMed Web of Science ®Google Scholar
• Wang JL , LiuJ, XieKG, LanCG, LuL, TangYJ. Association between functional polymorphisms in IL-33/ST2 pathway and risk of osteosarcoma. J. Cell Mol. Med.13653 (2018).
   Web of Science ®Google Scholar
• Wei ZH , LiYY, HuangSQ, TanZQ. Genetic variants in IL-33/ST2 pathway with the susceptibility to hepatocellular carcinoma in a Chinese population. CytokineS1043-S4666(18), 30122–30124 (2018).
   Google Scholar